{
    "nctId": "NCT02961764",
    "officialTitle": "A Pragmatic Trial Designed to Evaluate a New Critical Pathway for Treatment of Patients With Acute Bacterial Skin and Skin Structure Infections",
    "inclusionCriteria": "* Presents to the Emergency Department (ED) and meets the clinical definition for Acute Bacterial Skin and Skin Structure Infections (ABSSSI)\n* Known or suspected gram-positive infection.\n* Must have minimum age of 18 Years",
    "exclusionCriteria": "* Known or suspected gram-negative infections, anaerobic infections, or fungemia\n* Known or suspected infections that are severe, life threatening or are not included in the ABSSSI Food and Drug Administration (FDA) guidance\n* Injection drug users with a fever\n* Severe neurological disorder leading to immobility or confined to a wheelchair\n* Bilateral Lower extremity involvement of the suspected infection."
}